Presentation is loading. Please wait.

Presentation is loading. Please wait.

Stock and Flow of Peritoneal Dialysis Patients Australia

Similar presentations


Presentation on theme: "Stock and Flow of Peritoneal Dialysis Patients Australia"— Presentation transcript:

1 Stock and Flow of Peritoneal Dialysis Patients Australia 2001 - 2005
Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 1796 Patients

2 Stock and Flow of Peritoneal Dialysis Patients New Zealand 2001 - 2005
Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 720 Patients

3 Age of New PD Patients 2005 Australia No.
Pats

4 Age of Dialysing PD Patients 31-Dec-2005
Australia No. Pats

5 PD Patients (%) of all Prevalent Dialysis
Australia 31-Dec-2005

6 Number (Per Million) Prevalent PD Patients
Australia % Diab 24% % % % %

7 Number of Prevalent APD/CAPD Patients
Australia % APD 28% % % % %

8 Number (Per Million) Prevalent APD Patients
Australia % Diab 20% % % % %

9 PD Patients (%) of all Prevalent Dialysis
New Zealand 31-Dec-2005

10 Number (Per Million) Prevalent PD Patients
New Zealand % Diab 39% % % % %

11 Number of Prevalent APD/CAPD Patients
New Zealand % APD 16% % % % %

12 Number (Per Million) Prevalent APD Patients
New Zealand % Diab 29% % % % %

13 Age of New PD Patients 2005 New Zealand No.
Pats

14 Age of Dialysing PD Patients
New Zealand 31-Dec-2005 No. Pats

15 Patient Survival - PD at 90 days Censored for Transplant
0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years (1650) (1705) (1844) (1861) Patient Survival - PD at 90 days Censored for Transplant Australia

16 Patient Survival - PD at 90 days Censored for Transplant
New Zealand 1.00 0.75 Probability of survival 0.50 0.25 (500) (545) (664) (647) 0.00 1 2 3 4 5 Years

17 Patient Survival - PD at 90 days Censored for Transplant
0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years Non-diabetic (5272) Diabetic (1788) Patient Survival - PD at 90 days Censored for Transplant Australia

18 Patient Survival - PD at 90 days Censored for Transplant
0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years Non-diabetic (1379) Diabetic (1027) Patient Survival - PD at 90 days Censored for Transplant New Zealand

19 Patient Survival - PD at 90 days Censored for Transplant
0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years <40 (1062) 40-59 (2110) 60-74 (2970) >=75 (918) Patient Survival - PD at 90 days Censored for Transplant Australia

20 Patient Survival - PD at 90 days Censored for Transplant
0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years <40 (367) 40-59 (957) 60-74 (909) >=75 (173) Patient Survival - PD at 90 days Censored for Transplant New Zealand

21 Adjusted Patient Survival - PD at 90 days Censored for Transplant
Australia 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years (1650) (1705) (1844) (1861)

22 Adjusted Patient Survival - PD at 90 days Censored for Transplant
New Zealand 1.00 0.75 Probability of survival 0.50 0.25 (500) (545) (664) (647) 0.00 1 2 3 4 5 Years

23 First PD Treatment to First Peritonitis Related to Age at Entry 2001 - 2005
% Survival Australia Age Group

24 First PD Treatment to First Peritonitis Related to Age at Entry 2001 - 2005
% Survival New Zealand Age Group

25 First PD Treatment to First Peritonitis Related to Race
Australia Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs Aboriginal/Torres St Maori/Pacific People 55-64 yrs

26 First PD Treatment to First Peritonitis Related to Race
Australia Caucasoid 55-64 yrs 35-54 yrs 55-64 yrs Aboriginal/Torres St Maori/Pacific People 35-54 yrs

27 First PD Treatment to First Peritonitis Related to Race
New Zealand Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Maori/Pacific People

28 First PD Treatment to First Peritonitis Related to Race
New Zealand Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Maori/Pacific People

29 Number of PD Episodes Number of PD episodes per person Proportion .6
.4 Proportion .2 5 10 Number of PD episodes per person

30

31 Vancomycin by Organism
Gram positives only Culture negative Coag neg Staph MRSA Staph aureus non MRSA Other Gram Pos .2 .4 .6 .8 Proportion Vancomycin in antibiotic regimen First Second

32 Initial Antibiotic Regimen
.8 .6 Proportion of initial antibiotic regimens .4 .2 NT NSW/ACT Vic Qld SA WA Tas Initial antibiotic regimen Vancomycin Aminoglycoside


Download ppt "Stock and Flow of Peritoneal Dialysis Patients Australia"

Similar presentations


Ads by Google